$3.01
-0.05-1.63%
At close: -
$3.04
0.031.00%
After Hours: 6:48 PM EDT
Comments
Loading...
Aquestive Therapeutics (AQST) Forecast
NewsEarningsAquestive Therapeutics (AQST) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAquestive Therapeutics (NASDAQ:AQST) Stock Quotes, Forecast and News Summary
Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aquestive Therapeutics (AQST) stock?
You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.
Who are Aquestive Therapeutics (AQST) competitors?
Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), SNDL (NASDAQ:SNDL) and Bioage Labs (NASDAQ:BIOA).
What is the forecast, or price target, for Aquestive Therapeutics (AQST) stock?
Aquestive Therapeutics has a consensus price target of $9.85.
What is the current price for Aquestive Therapeutics (AQST)?
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $3.04 last updated February 21, 2025 at 6:48 PM EST.
Does Aquestive Therapeutics (AQST) pay a dividend?
There are no upcoming dividends for Aquestive Therapeutics.
When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?
Aquestive Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Aquestive Therapeutics (AQST) going to split?
There is no upcoming split for Aquestive Therapeutics.
What sector and industry does Aquestive Therapeutics (AQST) operate in?
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.